Efforts to find a drug that may slow the progression of Alzheimer's disease saw a glimmer of hope this week in a small trial using an experimental treatment. Researchers are testing the drug, known as LMTM and made by TauRx Therapeutics, Ltd. of Singapore, to see if it can reduce the accumulation of the protein tau in the brain. When tau malfunctions, the brain can form protein tangles that are believed to cause Alzheimer's, the most common form of dementia.
By Chine Labbé and Michel Rose PARIS/SAINT-ETIENNE-DU-ROUVRAY, France (Reuters) - Police had been hunting the second teenager who killed a priest in a church in France this week after a foreign intelligence tipoff that a suspected jihadist might be preparing an attack, police and judicial sources said. The revelation is likely to further fuel criticism by opposition politicians that President Francois Hollande's Socialist government did not do enough to stop the pair given that they were both already known to intelligence services. Police had already identified 19-year-old Adel Kermiche as one of the attackers.